EditCo Bio
PrivateLast Round
VC Round
Mar 27, 2024
Company Overview
EditCo Bio is a biotechnology company that provides CRISPR-engineered cell models and high-throughput gene editing solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EditCo Bio Comparables
Compare EditCo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRION Biotech | 79% | |
| Synthego | 77% | |
| Applied StemCell, Inc. | 76% |
EditCo Bio Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
EditCo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Telegraph Hill Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 119% MoM, reaching 19.3K.
- Nov 27, 2024
Grew 16% QoQ, from 79 to 92 employees.
EditCo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EditCo Bio's valuation, stock price, and market status.
Is EditCo Bio a public or private company?
EditCo Bio is a private company.
What is the current stock price of EditCo Bio?
EditCo Bio is a private company, so its shares have no public market price. Caplight tracks EditCo Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EditCo Bio worth (valuation)?
Valuation information for EditCo Bio is not publicly available.
Can I buy EditCo Bio stock?
EditCo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EditCo Bio's last funding round?
EditCo Bio's most recent funding round was VC Round on March 27, 2024.
Who are the main investors in EditCo Bio?
Key investors in EditCo Bio include Telegraph Hill Partners.
Will EditCo Bio IPO soon?
No public IPO plans have been announced for EditCo Bio.
How can I track EditCo Bio secondary market activity?
Caplight tracks bids, offers, and trades in EditCo Bio's shares on secondary markets.